InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2016-12-30 | Carlos Mr Curbelo | house | Sale | $1,001 - $15,000 |
| 2016-05-31 | James French Hill(R-AR02) | house | Purchase | $15,001 - $50,000 |
| 2016-05-25 | Carlos Curbelo | house | Purchase | $1,001 - $15,000 |
No financial data available for IBB.
Company may not file with SEC or CIK is unresolved.
Medical Technology Stocks: Innovation Endures As Valuations Reset
Exchange-Traded Funds Higher, Equity Futures Mixed Amid Continued Earnings Results
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Amid Big Tech Earnings, Economic Data
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Wednesday Ahead of Fed Policy Decision
Gilead Sciences Crosses Critical Breakout Level. The Stock Can Gain 35% From Here.
SBIO: Leaning Into Drug Discovery And Medical Breakthroughs
Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Tuesday Amid Higher Oil Prices, Earnings Deluge
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
Exchange-Traded Funds Down, Equity Futures Mixed Pre-Bell Monday Amid Hormuz Uncertainty, Corporate Earnings
Legend Biotech: Undervalued Leader In The CAR-T Race
Exchange-Traded Funds Rise, Equity Futures Mixed Pre-Bell as Traders Assess Tech Earnings Amid Global Uncertainty
JPMorgan analyst sees opportunities in healthcare and financials